Evoke plc (LON:EVOK – Get Free Report) shares traded down 10% during mid-day trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analysts Set New Price Targets
Several analysts recently commented on EVOK shares. Berenberg Bank cut their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group reiterated a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th.
View Our Latest Analysis on EVOK
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, equities research analysts predict that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Activity at Evoke
In related news, insider Andrea Gisle Joosen bought 14,572 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was bought at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is owned by insiders.
Evoke Company Profile
Featured Articles
- Five stocks we like better than Evoke
- Investing In Automotive Stocks
- MarketBeat Week in Review – 03/24 – 03/28
- Market Cap Calculator: How to Calculate Market Cap
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How Technical Indicators Can Help You Find Oversold Stocks
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.